Laboratorio Farmaceutico Erfo SpA is an Italy-based pharmaceutical company primarily engaged in the nutraceutical sector. The Company specializes in the production of nutritional supplements, that thanks to research and development carried out internally and in collaboration with the University Campus Bio-Medico of Rome and the University of Messina provides products with a scientific value in different therapeutic areas. The Company operates globally.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
02/26/02	€1.140	+0.44%	23,000
01/26/01	€1.135	-1.30%	23,000
31/26/31	€1.150	0.00%	21,000
28/26/28	€1.150	+1.32%	17,000
27/26/27	€1.135	-0.44%	8,000

Real-time Borsa Italiana

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Borsa Italiana 09:15:00 02/09/2026 pm IST			5-day change	1st Jan Change
1.140 ^EUR	+0.44%		0.00%	-22.45%

31/08	Milan in the pink at the open, oil stocks lead the MIB	AN
31/08	Futures weak; Brent higher after US-Iran attacks	AN

Market Cap	96.7L 1.12Cr 91.1L 83L 1.55Cr 105.89Cr 1.56Cr 11Cr 4.19Cr 54Cr 4.21Cr 4.12Cr 177.84Cr	P/E 2024	30.8x	P/E 2025	17x
Enterprise Value	99.66L 1.16Cr 93.88L 85.53L 1.6Cr 109.12Cr 1.61Cr 11Cr 4.31Cr 56Cr 4.34Cr 4.24Cr 183.27Cr	EV / Sales 2024	1.79x	EV / Sales 2025	1.32x
Free-Float	33.31%	Yield 2024 *	-	Yield 2025	-

31/08	Milan in the pink at the open, oil stocks lead the MIB	AN
31/08	Futures weak; Brent higher after US-Iran attacks	AN
28/08	Buying across Europe, Lottomatica goes all-in on the MIB	AN
28/08	Europe pushes higher at the halfway mark, MIB at 52,700	AN
27/08	Laboratorio Farmaceutico Erfo closes half-year with revenue up 2%	AN
27/08	Milan opens lower; STM jumps after Nvidia earnings	AN
26/08	Piazza Affari ends higher, Buzzi leads the MIB	AN
06/07	Laboratorio Erfo continues buyback, acquires 15,000 treasury shares	AN
29/06	Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares	AN
22/06	Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares	AN
20/06	Laboratorio Farmaceutico Erfo S.p.A.'s Equity Buyback announced on December 18, 2024, has expired.	CI
15/06	Laboratorio Farmaceutico Erfo acquires 15,000 treasury shares	AN
04/06	Equities trend higher; banks lead gains on the MIB	AN

09/04	Laboratorio Farmaceutico Erfo S p A : Investor Presentation Erfo SpA FY2025 (ENG)	PU
21/25/21	Laboratorio Farmaceutico Erfo S p A : 2025 10 20-ERFO-NextGEMS	PU
29/25/29	Laboratorio Farmaceutico Erfo S p A : 2025 08 28 ERFO - Press release KPI 1H 2025	PU
04/25/04	Laboratorio Farmaceutico Erfo S p A : KT Erfo 1Q25 Final	PU
19/25/19	Laboratorio Farmaceutico Erfo S p A : KT Erfo FY24 Final	PU

Laboratorio Farmaceutico Erfo S.p.A. Share Price

Stocks

ERFO

IT0005497885

Pharmaceuticals

Valuation : Laboratorio Farmaceutico Erfo S.p.A.

Chart: Laboratorio Farmaceutico Erfo S.p.A.

Latest news : Laboratorio Farmaceutico Erfo S.p.A.

Press Releases : Laboratorio Farmaceutico Erfo S.p.A.

News in other languages : Laboratorio Farmaceutico Erfo S.p.A.

Quotes and Performance

Price Extremes

Managers and Directors : Laboratorio Farmaceutico Erfo S.p.A.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

31/08	Milano maglia rosa in avvio; sul MIB guidano le oil
31/08	Futures deboli; Brent su dopo attacchi USA-Iran
28/08	Buy in tutta Europa, Lottomatica fa all-in sul MIB
28/08	Europee di slancio al giro di boa; MIB a 52.700
27/08	Laboratorio Farmaceutico Erfo archivia semestre con ricavi su del 2%

1 day	+0.44%
Current month	-0.87%
1 month	-2.98%
3 months	+3.64%
6 months	-5.79%
Current year	-22.45%

1 week	1.11	1.18
1 month	1.08	1.18
Current year	1.01	1.6
1 year	1.01	1.8
3 years	0.88	1.8
5 years	0.88	3.3
10 years	0.88	3.3

Manager	Title	Age	Since
Alessandro Cutè CEO	Chief Executive Officer	56	01/01/2013
Daniele Travisano DFI	Director of Finance/CFO	-	-

Director	Title	Age	Since
Alessandro Cutè CHM	Chairman	56	01/01/2013
Flavio Corpina BRD	Director/Board Member	47	01/01/2017
Fabio Giuffre BRD	Director/Board Member	45	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
16/12/25	Alessandro Cutè	Sell	Chief Executive Officer	9,68,000	10.7556%
16/12/25	Alessandro Cutè	Sell	Chief Executive Officer	3,22,000	3.5778%
29/06/22	Alessandro Cutè	Others	Chief Executive Officer	3,00,000	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LABORATORIO FARMACEUTICO ERFO S.P.A.	+0.44%	0.00%	-28.30%	-2.56%	1.12Cr
ELI LILLY AND COMPANY	+0.27%	-2.05%	+58.47%	+108.72%	1,03400Cr
JOHNSON & JOHNSON	+1.64%	+1.86%	+54.46%	+71.17%	65TCr
ABBVIE INC.	+0.27%	-0.87%	+22.98%	+78.38%	46TCr
ROCHE HOLDING AG	+0.49%	-5.19%	+33.28%	+35.53%	34TCr
NOVARTIS AG	+0.27%	+3.26%	+29.76%	+47.50%	31TCr
ASTRAZENECA PLC	+0.12%	-2.11%	+0.60%	+12.03%	25TCr
AMGEN INC.	+0.67%	+0.16%	+53.72%	+73.63%	24TCr
NOVO NORDISK A/S	+2.64%	-1.08%	-15.85%	-53.97%	20TCr
GILEAD SCIENCES, INC.	-0.26%	+0.81%	+32.45%	+98.62%	19TCr
Average	+0.66%	-2.55%	+24.16%	+46.90%	36.72TCr
Weighted average by Cap.	+0.65%	-3.31%	+38.91%	+67.98%

	2024	2025
Net sales	60.32L 69.92L 56.83L 51.78L 96.78L 66Cr 97.5L 6.73Cr 2.61Cr 34Cr 2.63Cr 2.57Cr 110.94Cr	97.32L 1.13Cr 91.67L 83.53L 1.56Cr 106.56Cr 1.57Cr 11Cr 4.21Cr 54Cr 4.24Cr 4.14Cr 178.97Cr
Net income	4L 4L 3L 3L 6L 3.86Cr 6L 39.35L 15.27L 1.98Cr 15.36L 15.02L 6.49Cr	7L 9L 7L 6L 11.82L 8.07Cr 11.91L 82.19L 31.9L 4.13Cr 32.08L 31.38L 14Cr
Net Debt	5.77T 6.68T 5.43T 4.95T 9.25T 6L 9.32T 64.32T 24.96T 3L 25.1T 24.55T 10.61L	3L 3L 3L 3L 5L 3.23Cr 5L 32.95L 12.79L 1.65Cr 12.86L 12.58L 5.43Cr